Conference
Phase I/II study of CTCE-9908, a novel anticancer agent that inhibits CXCR4, in patients with advanced solid cancers
Authors
Hotte SJ; Hirte HW; Iacobucci A; Wong D; Cantin L; Korz W; Miller WH
Volume
6
Pagination
pp. 3385S-3386S
Publisher
AMER ASSOC CANCER RESEARCH
Publication Date
December 1, 2007
Conference proceedings
MOLECULAR CANCER THERAPEUTICS
Issue
12
ISSN
1535-7163